登录 | 注册

热门期刊: 细胞研究(英文版)中华医学杂志(英文版)国际临床研究杂志

相关学者

相关机构

新冠肺炎治愈患者接种新冠病毒疫苗不同剂次抗体水平分析

Novel coronavirus pneumonia cured patients vaccinated COVID-19 Different doses of vaccine Antibody level analysis

ES评分10   

DOI 10.12208/j.ijcr.20220007
刊名
International Journal of Clinical Research
年,卷(期) 2022, 6(1)
作者
作者单位

湖北省赤壁市疾病预防控制中心 湖北赤壁 ;
湖北省赤壁市疾病预防控制中心 湖北赤壁 ;

摘要
研究新冠肺炎治愈患者接种新冠病毒灭活疫苗不同剂次的免疫效果。方法 将2020年赤壁市按现住址统计在中国疾病预防控制传染病报告信息管理系统报告的新冠肺炎治愈患者,自愿接受关爱康复项目,并签订知情同意书的84人纳入研究对象。采取询问新冠肺炎疫苗接种情况和对其进行新冠病毒抗体IgM及IgG检测,将检测出的1剂和2剂IgG抗体水平平均值进行T检验。结果 58人接种了1剂新冠病毒疫苗的新冠病毒IgG抗体水平在1.71~8.61范围,均数为6.56±1.68;22人接种的2剂新冠病毒疫苗,新冠病毒IgG抗体水平在0.29~8.56范围,均数为5.71±2.35,经T检验,t=0.72 P>0.05,两者IgG水平无统计差异。结论 1、新冠肺炎治愈患者接种新冠病毒灭活疫苗只需要接种1剂,没必要接种2剂。2、部分没有接种新冠病毒疫苗的治愈患者,IgG抗体水平保持时间可达1年7个月之久。
Objective Chinas novel coronavirus pneumonia was treated novel coronavirus pneumonia patients with different doses of COVID-19 inactivated vaccine. Methods: in 2020, Chibi City, according to the current address, was collected from the new crown pneumonia patients reported by the China Disease Control and prevention reporting information management system, and the 84 people who voluntarily accepted the care rehabilitation project and signed informed consent were included in the study. A novel coronavirus pneumonia vaccine was inoculated and the IgM and IgG levels of COVID-19 antibodies were tested. The average level of 1 and 2 IgG antibodies tested was tested by T. Results: the IgG antibody level of 58 people inoculated with 1 doses of COVID-19 vaccine ranged from 1.71 to 8.61, with a mean of 6.56±1.68. The 2 doses of COVID-19 vaccine inoculated with 22 persons and the level of COVID-19 IgG antibody ranged from 0.29 to 8.56, the mean value was 5.71 ±2.35. After T test, t=0.72 P > 0.05, there was no statistical difference in IgG level between the two groups. Conclusion: 1. Novel coronavirus pneumonia patients who received COVID-19 inactivated vaccine only need 1 doses of inoculation, and no need to inoculate 2 doses. 2. Some patients who did not receive COVID-19 vaccine were able to maintain the level of IgG antibody for 1 years and 7 months.
关键词
新冠肺炎;治愈患者;接种疫苗;抗体水平
Novel Coronavirus Pneumonia; Cured Patients; Vaccination; Antibody Level
基金项目
页码 127-130
  • 参考文献
  • 相关文献

[1] World Health Organization. WHO Coronavirus Disease (COVID-19)Dashboard[EB/OL].[2021-04-06].https://covid19.who.int/.<br>

[2] 陈沐,韩俊彦,张德荣,李世闻,莫晓能.接种新型冠状病毒灭活疫苗(Vero细胞)后感染COVID-19病例的临床特征及抗体情况[J].中国热带医学, 2021, 21(10): 985-989.DOI:10.13604/j.cnki.46-1064/r.2021.10.15.<br>

[3] 李晓珍,曹文婷,刘尚滨,黄海溶.海南省168例新型冠状病毒肺炎患者流行病学特征分析[J].海南医学院学报,2020,26(09):641-645.DOI:10.13210/j.cnki.jhmu.20200421.002.<br>

[4] 王爱华,龙泉,田春.重庆市渝西地区新冠肺炎确诊病例首发症状及流行病学特征[J].中国感染控制杂志,2020,19(03):234-238.<br>

[5] 熊亚莉、徐庆庆、唐健. 新型冠状病毒特异性抗体的动态变化和临床意义[J]. 医学研究生学报, 2020, 33(9):5.<br>

[6] ZHAO J,ZHAO S,OU J X.et al.COVID-19:coronavirus vaccine development updates[J]. Front Immunol. 2020, 11: 602256.<br>

  • 文献评论

2022-10-27 01:57:37

这个比较实用。